SCHEMBL30169063

SCHEMBL30169063

CC(C)(C)OC(=O)N[C@@H](CCC(N)=O)COc1cccc(CC(=O)O)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 1/20 0.42
▸ HDAC3 O15379 1/20 0.40
▸ HDAC4 P56524 1/20 0.40
▸ HDAC1 Q13547 1/20 0.40
▸ HDAC7 Q8WUI4 1/20 0.40
▸ HDAC2 Q92769 1/20 0.40
▸ HDAC10 Q969S8 1/20 0.40
▸ HDAC11 Q96DB2 1/20 0.40
▸ HDAC8 Q9BY41 1/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.40
▸ HDAC9 Q9UKV0 1/20 0.40
▸ HDAC5 Q9UQL6 1/20 0.40
▸ ACE P12821 1/20 0.39
▸ APP P05067 1/20 0.39
▸ F10 P00742 2/20 0.38
▸ SYK P43405 1/20 0.38
▸ PLA2G4B P0C869 1/20 0.38
▸ PPARA Q07869 1/20 0.38
▸ AAK1 Q2M2I8 3/20 0.38
▸ CTSS P25774 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22527004 1.00 ATM (0.42) ATMHDAC3HDAC4HDAC1HDAC7
SCHEMBL22526462 0.91 CACNA1B (0.40) ATMHDAC3HDAC4HDAC1HDAC7
SCHEMBL30169343 0.91 ATM (0.43) ATMHDAC3HDAC4HDAC1HDAC7
SCHEMBL30169362 0.91 CACNA1B (0.40) ATMHDAC3HDAC4HDAC1HDAC7
SCHEMBL22526731 0.89 ATM (0.40) ATMHDAC3HDAC4HDAC1HDAC7
SCHEMBL30169219 0.89 ATM (0.40) ATMHDAC3HDAC4HDAC1HDAC7
SCHEMBL30169110 0.89 CYSLTR2 (0.41) ATMHDAC3HDAC4HDAC1HDAC7
SCHEMBL22526872 0.88 HDAC1 (0.41) ATMHDAC3HDAC4HDAC1HDAC7
SCHEMBL25383035 0.88 PPARA (0.43) ATMHDAC3HDAC4HDAC1HDAC7
SCHEMBL22525550 0.88 PPARA (0.43) ATMHDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250059221-A1 STAT DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. 2025-02-20 — — US disclosed
US-12077555-B2 STAT degraders and uses thereof KYMERA THERAPEUTICS, INC. (US) 2024-09-03 — — US disclosed
US-11746120-B2 Stat degraders and uses thereof KYMERA THERAPEUTICS, INC. (US) 2023-09-05 — — US disclosed
US-20230120381-A1 STAT DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. 2023-04-20 — — US disclosed
US-20230084113-A1 STAT DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. 2023-03-16 — — US disclosed
US-11485750-B1 STAT degraders and uses thereof KYMERA THERAPEUTICS, INC. (US) 2022-11-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230084113-A1 STAT DEGRADERS AND USES THEREOF STAT4, STAT1, STAT3 ATM 837/4885HDAC3 184/4885HDAC4 347/4885
US-20230120381-A1 STAT DEGRADERS AND USES THEREOF STAT4, STAT1, STAT3 ATM 837/4885HDAC3 184/4885HDAC4 347/4885
US-12077555-B2 STAT degraders and uses thereof STAT4, STAT1, STAT3 ATM 837/4885HDAC3 184/4885HDAC4 347/4885
US-20250059221-A1 STAT DEGRADERS AND USES THEREOF STAT4, STAT1, STAT3 ATM 837/4885HDAC3 184/4885HDAC4 347/4885
US-11746120-B2 Stat degraders and uses thereof STAT4, STAT1, STAT3 ATM 837/4885HDAC3 184/4885HDAC4 347/4885
US-11485750-B1 STAT degraders and uses thereof STAT4, STAT1, STAT3 ATM 837/4885HDAC3 184/4885HDAC4 347/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback